Stemness, Inflammation and Epithelial-Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network.
colorectal cancer
epithelial–mesenchymal transition
immunohistochemistry
inflammation
stem cells
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Nov 2021
29 Nov 2021
Historique:
received:
04
10
2021
revised:
22
11
2021
accepted:
25
11
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
27
1
2022
Statut:
epublish
Résumé
In global cancer statistics, colorectal carcinoma (CRC) ranks third by incidence and second by mortality, causing 10.0% of new cancer cases and 9.4% of oncological deaths worldwide. Despite the development of screening programs and preventive measures, there are still high numbers of advanced cases. Multiple problems compromise the treatment of metastatic colorectal cancer, one of these being cancer stem cells-a minor fraction of pluripotent, self-renewing malignant cells capable of maintaining steady, low proliferation and exhibiting an intriguing arsenal of treatment resistance mechanisms. Currently, there is an increasing body of evidence for intricate associations between inflammation, epithelial-mesenchymal transition and cancer stem cells. In this review, we focus on inflammation and its role in CRC stemness development through epithelial-mesenchymal transition.
Identifiants
pubmed: 34884696
pii: ijms222312891
doi: 10.3390/ijms222312891
pmc: PMC8658015
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Br J Cancer. 2013 Apr 16;108(7):1449-59
pubmed: 23511563
J Clin Pathol. 2004 Nov;57(11):1160-4
pubmed: 15509676
Front Oncol. 2019 Apr 30;9:309
pubmed: 31114754
Int J Radiat Biol. 2014 Aug;90(8):687-99
pubmed: 24650104
J Inflamm Res. 2020 Jan 08;13:15-34
pubmed: 32021376
Cancer Med. 2020 Jan;9(1):361-373
pubmed: 31693304
Histopathology. 2021 Jan;78(2):252-264
pubmed: 32654226
Histopathology. 2012 Dec;61(6):1072-81
pubmed: 23020521
Nature. 1996 Oct 3;383(6599):443-6
pubmed: 8837778
Gut. 2020 Sep;69(9):1645-1658
pubmed: 31953252
Anticancer Res. 2015 Nov;35(11):6111-20
pubmed: 26504037
J Gastrointest Cancer. 2019 Dec;50(4):824-837
pubmed: 30136202
Int J Mol Sci. 2018 Apr 06;19(4):
pubmed: 29642386
Mol Cancer. 2007 Apr 16;6:29
pubmed: 17437633
Nutrients. 2018 Jul 12;10(7):
pubmed: 30002278
Cell Cycle. 2013 Feb 1;12(3):511-21
pubmed: 23324344
BMC Cancer. 2013 Mar 22;13:145
pubmed: 23522088
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a000158
pubmed: 20300203
Arch Dermatol Res. 2013 Jan;305(1):35-47
pubmed: 22740085
Mediators Inflamm. 2018 Oct 9;2018:4867234
pubmed: 30402042
JCI Insight. 2020 Jun 18;5(12):
pubmed: 32427590
Cells. 2021 May 10;10(5):
pubmed: 34068719
Int J Cancer. 2016 Apr 15;138(8):1971-81
pubmed: 26595254
Indian J Pathol Microbiol. 2020 Jan-Mar;63(1):32-37
pubmed: 32031119
Int J Mol Med. 2018 Aug;42(2):713-725
pubmed: 29786110
Nat Cell Biol. 2009 Apr;11(4):460-7
pubmed: 19287376
Int Rev Neurobiol. 2020;151:185-200
pubmed: 32448607
CA Cancer J Clin. 2018 Jul;68(4):297-316
pubmed: 29846940
Science. 1992 Oct 16;258(5081):424-9
pubmed: 1411535
J Mol Med (Berl). 2009 Nov;87(11):1097-104
pubmed: 19727638
Cancers (Basel). 2020 Jan 16;12(1):
pubmed: 31963305
Lab Invest. 2021 Jul;101(7):908-920
pubmed: 33958701
Am Surg. 2020 May;86(5):480-485
pubmed: 32684047
Stem Cells Transl Med. 2012 Aug;1(8):592-603
pubmed: 23197865
Oncol Rep. 2018 Aug;40(2):693-703
pubmed: 29845283
Mol Cancer. 2019 Mar 11;18(1):39
pubmed: 30857545
Anticancer Res. 2021 Mar;41(3):1407-1420
pubmed: 33788732
Cancers (Basel). 2020 May 22;12(5):
pubmed: 32455980
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
PLoS One. 2013;8(2):e56664
pubmed: 23431386
Oncogene. 2021 Jul;40(26):4440-4452
pubmed: 34108617
Arq Bras Cir Dig. 2021 Mar 22;33(4):e1568
pubmed: 33759958
Elife. 2015 Sep 22;4:e08022
pubmed: 26393419
Oncotarget. 2017 Apr 26;8(38):64373-64384
pubmed: 28969077
Cancers (Basel). 2021 Jan 06;13(2):
pubmed: 33419021
Biochem Biophys Rep. 2021 May 24;26:101031
pubmed: 34095556
Inflammopharmacology. 2019 Jun;27(3):627-638
pubmed: 30244296
J Clin Diagn Res. 2017 Jan;11(1):EC17-EC23
pubmed: 28273973
Clin Colorectal Cancer. 2018 Sep;17(3):e579-e592
pubmed: 29921496
Asian Pac J Cancer Prev. 2021 Aug 01;22(8):2429-2435
pubmed: 34452555
Hum Pathol. 1996 Sep;27(9):904-11
pubmed: 8816884
Genes (Basel). 2021 Sep 25;12(10):
pubmed: 34680897
Oncotarget. 2016 Aug 30;7(35):57066-57076
pubmed: 27494849
Ann Diagn Pathol. 2021 Jun;52:151739
pubmed: 33862415
Int J Cancer. 2014 Feb 1;134(3):519-29
pubmed: 23852449
Cancer Res. 2005 Nov 15;65(22):10413-22
pubmed: 16288032
Sci Rep. 2019 Dec 27;9(1):20027
pubmed: 31882967
Cancer. 2001 Nov 15;92(10):2539-46
pubmed: 11745187
J Clin Med. 2016 Apr 29;5(5):
pubmed: 27136592
Rom J Morphol Embryol. 2021 Jan-Mar;62(1):117-124
pubmed: 34609414
Ann Oncol. 2020 Oct;31(10):1291-1305
pubmed: 32702383
Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9
pubmed: 25190710
Cancer Sci. 2017 Jul;108(7):1357-1367
pubmed: 28421697
J Exp Clin Cancer Res. 2019 Jan 24;38(1):32
pubmed: 30678736
Lancet Gastroenterol Hepatol. 2020 May;5(5):475-484
pubmed: 32066530
Curr Stem Cell Res Ther. 2016;12(1):19-30
pubmed: 27593447
Hum Pathol. 2017 Feb;60:151-159
pubmed: 27836787
Cancers (Basel). 2021 Oct 20;13(21):
pubmed: 34771436
Clin Exp Pharmacol Physiol. 2020 May;47(5):838-847
pubmed: 31883392
Tumour Biol. 2016 Oct;37(10):14069-14081
pubmed: 27507615
Oncogene. 2013 Sep 26;32(39):4675-82
pubmed: 23085758
PLoS One. 2012;7(1):e30806
pubmed: 22295111
Clin Cancer Res. 2013 Feb 15;19(4):785-97
pubmed: 23251004
J Immunol. 2010 Dec 15;185(12):7443-51
pubmed: 21068403
Oncotarget. 2015 Nov 10;6(35):38029-45
pubmed: 26515729
Cells Tissues Organs. 2008;188(1-2):127-38
pubmed: 18160824
World J Exp Med. 2018 Sep 7;8(2):12-17
pubmed: 30211020
Pol J Pathol. 2015 Jun;66(2):176-94
pubmed: 26247532
Br J Cancer. 2013 Jul 23;109(2):379-86
pubmed: 23778530
World J Gastroenterol. 2018 Jan 7;24(1):124-138
pubmed: 29358889
Cancer Lett. 2014 Apr 10;345(2):271-8
pubmed: 23941828
Cells. 2021 Mar 11;10(3):
pubmed: 33799798
Oncol Lett. 2018 Feb;15(2):2380-2386
pubmed: 29434947
Blood. 2000 Feb 15;95(4):1207-13
pubmed: 10666192
Oncotarget. 2016 Dec 6;7(49):81144-81155
pubmed: 27835894
Exp Mol Med. 2021 Aug;53(8):1218-1228
pubmed: 34408262
Cells. 2020 Jan 17;9(1):
pubmed: 31963556
Cancer Sci. 2019 Sep;110(9):2806-2821
pubmed: 31254429
Mod Pathol. 2015 Mar;28(3):403-13
pubmed: 25216222
Br J Cancer. 2016 Feb 16;114(4):368-71
pubmed: 26766735
Br J Cancer. 2019 Feb;120(4):407-423
pubmed: 30713340
Int J Cancer. 2011 Nov 15;129(10):2315-27
pubmed: 21792897
Cell Stem Cell. 2014 Mar 6;14(3):275-91
pubmed: 24607403
Oncogene. 2008 Aug 28;27(37):5075-80
pubmed: 18469861
Ann Gastroenterol Surg. 2017 Dec 19;2(1):6-12
pubmed: 29863118
EMBO J. 1995 Nov 15;14(22):5618-25
pubmed: 8521819
Oncogenesis. 2018 Aug 9;7(8):57
pubmed: 30089773
Cancer Med. 2012 Aug;1(1):5-16
pubmed: 23342249
Eur J Intern Med. 2021 Nov;93:35-41
pubmed: 34481721
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Nat Cell Biol. 2019 Jan;21(1):102-112
pubmed: 30602760
Clin Cancer Res. 2012 Sep 1;18(17):4514-21
pubmed: 22711703
Ann Surg Oncol. 2019 Dec;26(13):4397-4404
pubmed: 31605345
Biochem Soc Trans. 2005 Aug;33(Pt 4):684-8
pubmed: 16042574
Oncol Rep. 2012 Oct;28(4):1301-8
pubmed: 22895640
Mol Cancer. 2019 Mar 30;18(1):64
pubmed: 30927925
Mod Pathol. 2016 May;29(5):516-27
pubmed: 26916075
Front Oncol. 2021 Aug 12;11:677646
pubmed: 34476209
Yonsei Med J. 2020 Jul;61(7):572-578
pubmed: 32608200
Front Oncol. 2019 Nov 18;9:1248
pubmed: 31803621